Paediatrics

-

 Paediatrics is a medical discipline focused on individuals from birth to the end of adolescence. The care of paediatric patients is different to that of adults, as many drugs are processed differently in these two groups. Growth and development are also more important in paediatric patients than in adults.

Comments

Post a Comment

Popular posts from this blog

AAP urges post-COVID-19 follow-up to monitor for residual symptoms

-
  New AAP interim guidance on post-COVID-19   conditions   in children and adolescents recommends all patients who test positive for SARS-CoV-2 infection have at least one follow-up conversation or visit with their pediatrician to discuss residual symptoms, explore new symptoms and guide their return to activities. More than 4 million U.S. children have tested positive for SARS-CoV-2. Although acute illness may be less severe in children and adolescents than adults, severity does not predict subsequent or ongoing symptoms. According to the guidance, “COVID-19 can lead to many secondary conditions, which can range from subacute to severe. Long-term effects from SARS-CoV-2 infection may be significant, regardless of the initial disease severity.” Post-COVID-19 check During the visit, pediatricians should work with families to identify any continuing symptoms of COVID19, which may include respiratory symptoms, cardiac symptoms, fatigue or cognitive fogginess. Pediatricians a...
Read more

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

-
  GATA2 deficiency is a heterogeneous multi-system disorder characterized by a high risk of developing myelodysplastic syndrome (MDS) and myeloid leukemia. We analyzed the outcome of 65 patients reported to the registry of the European Working Group (EWOG) of MDS in childhood carrying a germline  GATA2  mutation ( GATA2 mut ) who had undergone hematopoietic stem cell transplantation (HSCT). At 5 years the probability of overall survival and disease-free survival (DFS) was 75% and 70%, respectively. Non-relapse mortality and relapse equally contributed to treatment failure. There was no evidence of increased incidence of graft-versus-host-disease or excessive rates of infections or organ toxicities. Advanced disease and monosomy 7 (−7) were associated with worse outcome. Patients with refractory cytopenia of childhood (RCC) and normal karyotype showed an excellent outcome (DFS 90%) compared to RCC and −7 (DFS 67%). Comparing outcome of  GATA2 mut  with  GATA...
Read more